Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Clinical trial NCT04898894 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04898894
Sponsor: St. Jude Children's Research Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Leukemia of Ambiguous Lineage in Relapse Acute Myeloid Leukemia, in Relapse Refractory Acute Leukemia of Ambiguous Lineage Refractory Acute Myeloid Leukemia

Start date: 2021-11-15
Primary completion: 2023-07-12
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.